Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression
Biomolecules · 2025
DOI: 10.3390/biom15101369 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Zhonghao Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi 214122, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Prostatic Neoplasms. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation, the Wuxi Commission of Health and Family Planning, the Talent Plan of Taihu Lake in Wuxi (Double Hundred Medical Youth Professionals Program) from the Health Committee of Wuxi and Jiangsu Province 7th phase '33….
Abstract (Originalsprache)
The tumor microenvironment (TME) is crucial for tumor growth and progression, within which cancer-associated fibroblasts (CAFs) play a central role in regulating cancer cell proliferation, metastasis, and therapy resistance through various mechanisms. Although early-stage prostate cancer (PCa) has a high cure rate, advanced disease often becomes difficult to manage due to resistance to standard therapies such as androgen deprivation therapy (ADT). Therefore, a deep understanding of the interaction mechanisms between CAFs and PCa cells is essential for developing novel therapeutic strategies targeting resistant advanced PCa. This review systematically summarizes key signaling pathways and molecular mechanisms through which CAFs promote PCa progression, as recently discovered, evaluates the potential of CAFs as prognostic biomarkers, and discusses novel CAF-based therapeutic targets and intervention strategies for PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi 214122, China.
- Wuxi School of Medicine, Jiangnan University, 1800 Lihudadao, Wuxi 214122, China.
- Department of Pathology, Affiliated Hospital of Jiangnan University, 1000 Hefeng Road, Wuxi 214122, China.
ORCID-Profile: Yuanyuan Mi
Förderung
- the National Natural Science Foundation
- the Wuxi Commission of Health and Family Planning
- the Talent Plan of Taihu Lake in Wuxi (Double Hundred Medical Youth Professionals Program) from the Health Committee of Wuxi and Jiangsu Province 7th phase '33…
- National Natural Science Foundation
- Wuxi Commission of Health and Family Planning
- Talent Plan of Taihu Lake in Wuxi (Double Hundred Medical Youth Professionals Program) from the Health Committee of Wuxi
- Jiangsu Province 7th phase ‘333’ high-level talents
Zitieren
APA
Tang, Z., Shen, S., Gu, C., Li, S., Qin, Y., & Mi, Y. (2025). Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression. Biomolecules. https://doi.org/10.3390/biom15101369
Vancouver
Tang Z, Shen S, Gu C, Li S, Qin Y, Mi Y. Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression. Biomolecules. 2025. doi:10.3390/biom15101369
BibTeX
@article{Tang2025,
author = {Tang, Zhonghao and Shen, Si and Gu, Chenwei and Li, Sixin and Qin, Yan and Mi, Yuanyuan},
title = {Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15101369}
}
EUVIMED